Literature DB >> 1855986

Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activity.

M Amar1, N Amit, C Babin-Chevaye, T P Huu, J Hakim.   

Abstract

We have previously demonstrated that k562 malignant cells in culture contain and release a low-molecular-mass (8-kDa) factor that inhibits adherence-related functions of neutrophils but does not alter fMet-Leu-Phe- or phorbol ester-induced oxidative burst (M. Amar, N. Amit, T. Pham Huu, S. Chollet-Martin, M.T. Labro, M.A. Gougerot-Pocidalo, and J. Hakim, J. Immunol. 144:4749-4756, 1990). In this study, we investigated the effects of this factor, referred to as inhibitory factor 1 (IF1), on the bactericidal activity of human polymorphonuclear cells (PMNs) on Staphylococcus aureus opsonized in various ways. S. aureus was used either nonopsonized or opsonized with heat-inactivated serum or normal serum containing complement factors. The bactericidal activity of PMNs preincubated with IF1-treated or control medium was examined by counting the surviving bacteria. The ability of IF1-treated PMNs to kill bacteria was diminished when they were opsonized with normal serum. When S. aureus was not opsonized or was opsonized with heat-inactivated serum, the bactericidal activity of IF1-treated PMNs was similar to that of controls. Likewise, the phagocytosis of IF1-treated PMNs was diminished when S. aureus was opsonized with normal serum but was not altered when S. aureus was not opsonized or was opsonized with heat-inactivated serum. These results suggest that the decrease in killing might be due to defective ingestion. The chemiluminescence response of IF1-treated PMNs was inhibited when S. aureus was not opsonized or was opsonized with normal serum. No effect on chemiluminescence was observed when S. aureus was opsonized with heat-inactivated serum. These results suggest that IF1 interferes not only with S. aureus stimulation of PMNs via complement receptors but also with oxygen-dependent bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855986      PMCID: PMC258072          DOI: 10.1128/iai.59.8.2673-2676.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Production by K 562 cells of an inhibitor of adherence-related functions of human neutrophils.

Authors:  M Amar; N Amit; T P Huu; S Chollet-Martin; M T Labro; M A Gougerot-Pocidalo; J Hakim
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

2.  NK cell sensitivity of the leukemic K 562 cells; effect of sodium butyrate and hemin induction.

Authors:  M C Dokhelar; U Testa; W Vainchenker; Y Finale; C Tetaud; P Salem; T Tursz
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

3.  Antileukotactic properties of tumor cells.

Authors:  J P Brozna; P A Ward
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

4.  Direct measurement of phagosomal reactive oxygen by luminol-binding microspheres.

Authors:  T Uchida; T Kanno; S Hosaka
Journal:  J Immunol Methods       Date:  1985-02-28       Impact factor: 2.303

5.  Impaired metabolic activity of phagocytosing neutrophils in agnogenic osteomyelofibrosis with splenomegaly: a longitudinal study.

Authors:  C Marquetty; M T Labro-Bryskier; A Perianin; J Hakim
Journal:  Am J Hematol       Date:  1984-04       Impact factor: 10.047

6.  Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.

Authors:  D L Gordon; J Rice; J J Finlay-Jones; P J McDonald; M K Hostetter
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

7.  Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice.

Authors:  T Iwahi; A Imada
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Prognostic significant of functional defects of granulocytes in myeloproliferative disease.

Authors:  A Mazzone; G Ricevuti; M Rossi; S C Rizzo
Journal:  Oncology       Date:  1986       Impact factor: 2.935

9.  Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.

Authors:  G D Ross; J D Lambris
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Studies on granulocyte functions in patients with chronic myeloid leukemia.

Authors:  P N Anklesaria; S H Advani; A N Bhisey
Journal:  Tumori       Date:  1985-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.